Proliferation and significance of clinically relevant β-lactamases (Q38076454)

28 August 2017

1 reference

title

Proliferation and significance of clinically relevant β-lactamases (English)

1 reference

28 August 2017

Karen Bush

1

1 reference

PubMed ID

23346859

28 August 2017

language of work or name

English

0 references

publication date

1 January 2013

1 reference

Annals of the New York Academy of Sciences

28 August 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 August 2017

1277

1 reference

28 August 2017

84-90

1 reference

An Enzyme from Bacteria able to Destroy Penicillin

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Six groups of the OXY beta-Lactamase evolved over millions of years in Klebsiella oxytoca

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Antibiotic resistance is prevalent in an isolated cave microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Antibiotic resistance is ancient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Updated functional classification of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Minor extended-spectrum β-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

IRT and CMT beta-lactamases and inhibitor resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Metallo-β-lactamases: a last frontier for β-lactams?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Status report on carbapenemases: challenges and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Metallo-β-lactamase structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

The structure of β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Characterization of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

A functional classification scheme for beta-lactamases and its correlation with molecular structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Sequence of PSE-2 beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Fourteen years in resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

21 January 2018

OXA-type carbapenemases

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Three decades of beta-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

New β-lactam-β-lactamase inhibitor combinations in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Defining an extended-spectrum beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum β-lactamase producing gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Rationale for the 2010 Revised Susceptibility Breakpoints for Cephalosporins, Aztreonam, and Carbapenems for Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Identification and screening of carbapenemase-producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Global spread of Carbapenemase-producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

The emerging NDM carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Spread of carbapenemase NDM-1 producers: the situation in India and what may be proposed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

Evaluation of a DNA microarray for the rapid detection of extended-spectrum -lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and N

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12023

21 January 2018

Identifiers

DOI

10.1111/NYAS.12023

1 reference

release_echul74v7fcupa5x6awh7i4254

28 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/echul74v7fcupa5x6awh7i4254

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

23346859

1 reference

PubMed ID

23346859